TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33853731

Group type: EXPERIMENTAL
Intervention: Full-dose almonds (73±5 g/d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Half-dose almonds (38±3 g/d) plus half-dose muffins
Number of subjects: 0

Group type: COMPARATOR
Intervention: Full-dose muffins (control)
Number of subjects: 0
Study: 32494210

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (10 sessions over 3 weeks)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 72
Study: 35080256

Group type: EXPERIMENTAL
Intervention: Daclatasvir 60 mg plus alfosbuvir 400 mg daily (Cohort A)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Daclatasvir 60 mg plus alfosbuvir 600 mg daily (Cohort B)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Daclatasvir 60 mg plus alfosbuvir 800 mg daily (Cohort C)
Number of subjects: 124
Study: 34871153

Group type: EXPERIMENTAL
Intervention: Ciclesonide (CIC) 40, 80, or 160 µg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ciclesonide (CIC) 160 µg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ciclesonide (CIC) 80 or 160 µg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ciclesonide (CIC) with placebo
Number of subjects: 0
Study: 35809008

Group type: EXPERIMENTAL
Intervention: Prophylactic sacral dressing plus standard care
Number of subjects: 130

Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 130
Study: 33484216

Group type: EXPERIMENTAL
Intervention: Cardiac CT-guided LV lead implantation
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: LV stimulation in CT target segments
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Reverse remodeling at 6 months
Number of subjects: 18
Study: 35714057

Group type: EXPERIMENTAL
Intervention: Workshop (n = 65)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Waitlist control (n = 66)
Number of subjects: 131
Study: 32010972

Group type: COMPARATOR
Intervention: 24-hour Foley catheter (Group A)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: 48-hour Foley catheter (Group B)
Number of subjects: 201
Study: 34844129

Group type: EXPERIMENTAL
Intervention: Multisensory stimulation
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Montessori-based
Number of subjects: 84
Study: 33181518

Group type: EXPERIMENTAL
Intervention: 'bare' group (all pubic hair removed)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 'hair' group (no pubic hair removed)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (10 participants)
Number of subjects: 42
Study: 34265236

Group type: EXPERIMENTAL
Intervention: Ivermectin 12 mg on day 1 and 2 post enrolment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33228654

Group type: EXPERIMENTAL
Intervention: Self-report via telephone questionnaires
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Self-report via diaries
Number of subjects: 145

Group type: COMPARATOR
Intervention: Administrative data
Number of subjects: 145
Study: 35553398

Group type: EXPERIMENTAL
Intervention: Insufficient maternal vitamin D (< 50 nmol/l) during gestational weeks 18-22
Number of subjects: 176

Group type: COMPARATOR
Intervention: Sufficient maternal vitamin D (≥ 50 nmol/l) during gestational weeks 18-22
Number of subjects: 176
Study: 32506513

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin-E
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall change in MetS-Z
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Change-in-AST Z-score
Number of subjects: 0
Study: 33048951

Group type: EXPERIMENTAL
Intervention: Proposed model based on maternal fundal height
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Developed growth chart based on proposed model
Number of subjects: 20

Group type: COMPARATOR
Intervention: Existing fetal growth charts
Number of subjects: 20
Study: 36774103

Group type: EXPERIMENTAL
Intervention: Micellar casein (MCN)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sodium caseinate (SCN)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Whey protein concentrate (WPC)
Number of subjects: 10
Study: 34554201

Group type: EXPERIMENTAL
Intervention: Perioperative chemotherapy (fluorouracil dosing every 2 weeks)
Number of subjects: 0
Study: 36451377

Group type: EXPERIMENTAL
Intervention: Clinical guideline-based management by ayurvedic practitioners
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual ayurvedic management (without clinical guideline)
Number of subjects: 120
Study: 34187116

Group type: EXPERIMENTAL
Intervention: Yogasana
Number of subjects: 40

Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 40
Study: 35507530

Group type: EXPERIMENTAL
Intervention: Immediate Loading (IL)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Delayed Loading (DL)
Number of subjects: 14
Study: 34187554

Group type: EXPERIMENTAL
Intervention: PDT under endoscopic guidance (FB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blind PDT
Number of subjects: 0
Study: 33865361

Group type: EXPERIMENTAL
Intervention: Vitamin D (50,000 IU/week) plus Magnesium (6 mg/kg/day)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 33241650

Group type: EXPERIMENTAL
Intervention: Atezolizumab (1200 mg, every 3 weeks)
Number of subjects: 986
Study: 35550175

Group type: EXPERIMENTAL
Intervention: Brief Educational Tool to Enhance Recovery (BETTER) trial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Remote recruitment and consent process
Number of subjects: 0
Study: 34549539

Group type: EXPERIMENTAL
Intervention: Rucaparib (600 mg twice daily)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study: 32885374

Group type: EXPERIMENTAL
Intervention: BE-EHR module (six nudges)
Number of subjects: 680

Group type: COMPARATOR
Intervention: Control group (baseline)
Number of subjects: 680

Group type: COMPARATOR
Intervention: Control group (post intervention)
Number of subjects: 680
Study: 36209731

Group type: EXPERIMENTAL
Intervention: Monterizine (combination of montelukast and levocetirizine)
Number of subjects: 2254
Study: 34398113

Group type: EXPERIMENTAL
Intervention: Team size of 2 HCPs
Number of subjects: 109

Group type: COMPARATOR
Intervention: Team size of 3 HCPs
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Decision support tool (DST) use in the first scenario
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Decision support tool (DST) use in the second scenario
Number of subjects: 109

Group type: COMPARATOR
Intervention: Memory alone (control for DST)
Number of subjects: 109
Study: 33261603

Group type: EXPERIMENTAL
Intervention: Hearing aids fitted immediately (Fitted group)
Number of subjects: 427

Group type: COMPARATOR
Intervention: Routine care (Not Fitted group)
Number of subjects: 427
Study: 34241550

Group type: EXPERIMENTAL
Intervention: Generalized model trained on both Taiwanese and U.S. data
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Generalized model tested on U.S. data
Number of subjects: 536
Study: 32104689

Group type: EXPERIMENTAL
Intervention: Plasma GDF-15 level
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: MRC-score
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: RFcsa
Number of subjects: 95
Study: 35641047

Group type: EXPERIMENTAL
Intervention: DPPFit intervention (mobile health adaptation of the National Diabetes Prevention Program delivered via text messaging and Fitbit technology)
Number of subjects: 33
Study: 33762421

Group type: EXPERIMENTAL
Intervention: IV metoclopramide 20 mg + diphenhydramine 25 mg (M + D)
Number of subjects: 160

Group type: COMPARATOR
Intervention: IV placebo
Number of subjects: 160
Study: 33369462

Group type: EXPERIMENTAL
Intervention: Oral mefenamic acid (500 mg) 30 minutes before procedure
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (identical tablet) 30 minutes before operation
Number of subjects: 60
Study: 35687793

Group type: EXPERIMENTAL
Intervention: OC‐01 VNS 0.03 mg
Number of subjects: 1096

Group type: COMPARATOR
Intervention: CsA 0.05% ophthalmic emulsion
Number of subjects: 1096
Study: 33628014

Group type: EXPERIMENTAL
Intervention: 0.5 μg·kg‐1·h‐1 dexmedetomidine combined with butorphanol (3 μg·kg‐1·h‐1)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: 0.05 μg·kg‐1·h‐1 dexmedetomidine combined with butorphanol (3 μg·kg‐1·h‐1)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: 0.08 μg·kg‐1·h‐1 dexmedetomidine combined with butorphanol (3 μg·kg‐1·h‐1)
Number of subjects: 114

Group type: COMPARATOR
Intervention: 0.9% sodium chloride combined with butorphanol (3 μg·kg‐1·h‐1)
Number of subjects: 114
Study: 32461117

Group type: EXPERIMENTAL
Intervention: PVI + LA roof line + LA anterior wall line
Number of subjects: 214

Group type: COMPARATOR
Intervention: PVI + LA roof line
Number of subjects: 214
Study: 34180839

Group type: EXPERIMENTAL
Intervention: Standardized, physician-level quality measures submitted by family physicians
Number of subjects: 256

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 256
Study: 35442393

Group type: EXPERIMENTAL
Intervention: Digital health intervention with gamification (virtual teams, points, levels for daily step goal achievement)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control group receiving daily feedback on goal attainment
Number of subjects: 127
Study: 34911126

Group type: EXPERIMENTAL
Intervention: EHR reminders 'on' for primary immunization series during well-child visits
Number of subjects: 15343

Group type: EXPERIMENTAL
Intervention: EHR reminders 'on' for primary immunization series during acute care visits
Number of subjects: 15343

Group type: EXPERIMENTAL
Intervention: EHR reminders 'on' for up-to-date immunization overall
Number of subjects: 15343
Study: 32986770

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (IVL)
Number of subjects: 534

Group type: COMPARATOR
Intervention: No intravenous lidocaine (Control)
Number of subjects: 534
Study: 35384422

Group type: EXPERIMENTAL
Intervention: Fluvoxamine 100 mg twice daily for 10 days
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 52
Study: 34348011

Group type: EXPERIMENTAL
Intervention: Relaxation techniques (diaphragmatic breathing, progressive muscular relaxation, autogenic training, guided imagery) for 8 weeks, with weekly sessions and daily practice (2 times/day) using a compact disk.
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Relaxation techniques (treatment group).
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no relaxation techniques).
Number of subjects: 64
Study: 35619246

Group type: EXPERIMENTAL
Intervention: MT associated with active tDCS (a-tDCS)
Number of subjects: 28

Group type: COMPARATOR
Intervention: MT associated with sham tDCS (s-tDCS)
Number of subjects: 28
Study: 33326929

Group type: EXPERIMENTAL
Intervention: Musical stimulation (15 minutes once daily for 7 days using an MP3 player and headphones)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (silent headphones for 15 minutes once daily for 7 days)
Number of subjects: 54
Study: 32617889

Group type: EXPERIMENTAL
Intervention: HPV testing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Colposcopy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pap smear
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall sample
Number of subjects: 0
Study: 33043347

Group type: EXPERIMENTAL
Intervention: Combined treatment group (ornidazole + periodontal tissue regeneration)
Number of subjects: 100
Study: 34955070

Group type: EXPERIMENTAL
Intervention: Financial education and coaching program
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cocreating Knowledge Translation Framework
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Interventions at individual, relationship, and community levels
Number of subjects: 12
Study: 32960748

Group type: EXPERIMENTAL
Intervention: New glucose-lowering drug
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35775502

Group type: EXPERIMENTAL
Intervention: Universal HIV testing and treatment (UTT)
Number of subjects: 6259
Study: 34742266

Group type: EXPERIMENTAL
Intervention: Audio-recordings of breast reconstruction explanation of surgery
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard information package
Number of subjects: 32
Study: 33662923

Group type: EXPERIMENTAL
Intervention: Power training group (countermovement jump and bench press throw at 40% of the 1-repetition maximum [1RM])
Number of subjects: 20

Group type: COMPARATOR
Intervention: Strength training group (back squat and bench press at 70% to 90% of 1RM)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: iLOAD® application
Number of subjects: 20
Study: 35841716

Group type: EXPERIMENTAL
Intervention: Ofatumumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ocrelizumab
Number of subjects: 0
Study: 32102605

Group type: COMPARATOR
Intervention: Dynamic auditory cueing (music or audio books presented as moving dynamically from right to left)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dynamic meaningful auditory cues combined with optokinetic stimulation in a computer-based training
Number of subjects: 0
Study: 35248549

Group type: EXPERIMENTAL
Intervention: GB001 20 mg
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: GB001 40 mg
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: GB001 60 mg
Number of subjects: 480

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 480
Study: 33177130

Group type: EXPERIMENTAL
Intervention: Visualisation and pictorial representation of advanced structural vascular disease (abdominal aortic calcification)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Structured questionnaires and semistructured in-depth interviews
Number of subjects: 200
Study: 35251529

Group type: EXPERIMENTAL
Intervention: PFA‐ABCDE
Number of subjects: 221
Study: 32172441

Group type: EXPERIMENTAL
Intervention: Internet-based therapy for depressive symptoms
Number of subjects: 137
Study: 35281318

Group type: EXPERIMENTAL
Intervention: 0.5 μg/mL dexmedetomidine combined with 0.075% ropivacaine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Epidural dexmedetomidine (combined with 0.075% ropivacaine)
Number of subjects: 120

Group type: COMPARATOR
Intervention: 0 μg/mL dexmedetomidine combined with 0.075% ropivacaine
Number of subjects: 120

Group type: COMPARATOR
Intervention: 0.1 μg/mL dexmedetomidine combined with 0.075% ropivacaine
Number of subjects: 120

Group type: COMPARATOR
Intervention: 0.2 μg/mL dexmedetomidine combined with 0.075% ropivacaine
Number of subjects: 120

Group type: COMPARATOR
Intervention: 0.3 μg/mL dexmedetomidine combined with 0.075% ropivacaine
Number of subjects: 120

Group type: COMPARATOR
Intervention: 0.4 μg/mL dexmedetomidine combined with 0.075% ropivacaine
Number of subjects: 120
Study: 32624244

Group type: EXPERIMENTAL
Intervention: Fluocinolone acetonide insert (FAi) 0.2 μg/day
Number of subjects: 129
Study: 35212646

Group type: EXPERIMENTAL
Intervention: Surrounding needling combined with NBUVB phototherapy
Number of subjects: 28

Group type: COMPARATOR
Intervention: NBUVB phototherapy only
Number of subjects: 28

Group type: COMPARATOR
Intervention: Comparison of intervention vs control
Number of subjects: 28
Study: 33973063

Group type: EXPERIMENTAL
Intervention: Neuroticism
Number of subjects: 0

Group type: COMPARATOR
Intervention: MDD, SWB, and insomnia
Number of subjects: 0
Study: 32620212

Group type: EXPERIMENTAL
Intervention: Nivolumab alone (arms 1A and 4A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab for 4 injections followed by nivolumab alone (arms 1B and 4B)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab followed by nivolumab alone (arms 2B and 3B)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tyrosine kinase inhibitor (sunitinib or pazopanib at investigator's choice) (arms 2C and 3C)
Number of subjects: 0
Study: 35162381

Group type: EXPERIMENTAL
Intervention: Leg fidgeting (1 min on/4 min off)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (no leg fidgeting)
Number of subjects: 13
Study: 33123838

Group type: EXPERIMENTAL
Intervention: OPT‐A (integrated family‐based outpatient treatment)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Usual services
Number of subjects: 134
Study: 33017651

Group type: EXPERIMENTAL
Intervention: Airways therapy for OSA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control subjects (not treated for OSA)
Number of subjects: 0
Study: 35503131

Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 32760148

Group type: EXPERIMENTAL
Intervention: Proactive telephone peer support
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Volunteers' experiences
Number of subjects: 17
Study: 36385314

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) 6 mg kg−1
Number of subjects: 90
Study: 33999764

Group type: EXPERIMENTAL
Intervention: FNP2
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tru-Cut needle
Number of subjects: 20
Study: 32043326

Group type: EXPERIMENTAL
Intervention: Internal thoracic impedance (ITI) monitoring
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 70
Study: 35271721

Group type: EXPERIMENTAL
Intervention: Relighting cigarettes
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Frequency of smoking (number of smoking episodes/day)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Reduction in CPD
Number of subjects: 49
Study: 34448448

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 infection in primary school students
Number of subjects: 1119

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 infection in secondary school students
Number of subjects: 1119

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 infection in staff
Number of subjects: 1119

Group type: EXPERIMENTAL
Intervention: IgG antibodies in primary school students
Number of subjects: 1119

Group type: EXPERIMENTAL
Intervention: IgG antibodies in secondary school students
Number of subjects: 1119

Group type: EXPERIMENTAL
Intervention: IgG antibodies in household members
Number of subjects: 1119

Group type: EXPERIMENTAL
Intervention: Household attack rate after 1 week
Number of subjects: 1119
Study: 32554724

Group type: EXPERIMENTAL
Intervention: ASyMS-Can
Number of subjects: 114

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 114
Study: 35643334

Group type: EXPERIMENTAL
Intervention: rFOV-DWI
Number of subjects: 53

Group type: COMPARATOR
Intervention: SMS-RESOLVE-DWI
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: rFOV-DWI and SMS-RESOLVE-DWI
Number of subjects: 53
Study: 34841235

Group type: EXPERIMENTAL
Intervention: MIL60
Number of subjects: 517

Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 517
Study: 34897973

Group type: EXPERIMENTAL
Intervention: Students-mothers' education (2 sessions of 90 minutes)
Number of subjects: 261

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 261
Study: 33281043

Group type: EXPERIMENTAL
Intervention: 3 T magnetic resonance imaging (MRI)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no MRI exposure)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Different restorative materials
Number of subjects: 100
Study: 32379655

Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Static Touch
Number of subjects: 96
Study: 35780195

Group type: EXPERIMENTAL
Intervention: Ventilatory settings (median tidal volume 7 mL/PBW, PEEP 7 cmH20, plateau pressure 20 cmH20, driving pressure 12 cmH20, mechanical power 16.2 J/min, ventilatory ratio 1.27, respiratory rate 17 breaths/min)
Number of subjects: 1848
Study: 32281410

Group type: EXPERIMENTAL
Intervention: Antenatal education (two 2-hr sessions twice a week for 4 weeks)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no antenatal education)
Number of subjects: 120
Study: 32091467

Group type: EXPERIMENTAL
Intervention: Custom-fitted compression garments (CF, n = 13)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard-sized compression garments (SSG, n = 16)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham ultrasound therapy (CON, n = 16)
Number of subjects: 45
Study: 33177393

Group type: EXPERIMENTAL
Intervention: 1% benvitimod cream
Number of subjects: 686

Group type: COMPARATOR
Intervention: 0.005% calcipotriol ointment
Number of subjects: 686

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 686

Group type: EXPERIMENTAL
Intervention: 1% benvitimod cream (retreatment)
Number of subjects: 686
Study: 35366070

Group type: EXPERIMENTAL
Intervention: Left hand reaching with increased target distance
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Right hand reaching with visual feedback
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Right hand reaching without visual feedback
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Practice with randomized trial schedule
Number of subjects: 20
Study: 33302460

Group type: COMPARATOR
Intervention: Group Lifestyle Balance™ (GLB)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: lifestyle genomics (LGx)-based lifestyle intervention (GLB+LGx)
Number of subjects: 140
Study: 33605036

Group type: EXPERIMENTAL
Intervention: COMBO stent
Number of subjects: 440

Group type: COMPARATOR
Intervention: Nano polymer-free sirolimus-eluting stent
Number of subjects: 440
Study: 32607688

Group type: EXPERIMENTAL
Intervention: DOAC (apixaban, rivaroxaban, dabigatran)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 197
Study: 34218046

Group type: EXPERIMENTAL
Intervention: Dilution of apomorphine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subcutaneous hydrocortisone
Number of subjects: 0
Study: 32893706

Group type: EXPERIMENTAL
Intervention: Bronchodilators
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cortisone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapeutic modalities for ACS
Number of subjects: 0
Study: 36360666

Group type: EXPERIMENTAL
Intervention: Intralesional triamcinolone acetonide injection, periodontal scaling, and oral hygiene instruction (experimental group)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Intralesional triamcinolone acetonide injection (control group)
Number of subjects: 48